US5552155A
(en)
*
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
US5776486A
(en)
*
|
1993-05-28 |
1998-07-07 |
Aphios Corporation |
Methods and apparatus for making liposomes containing hydrophobic drugs
|
US5981501A
(en)
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
JPH11511128A
(ja)
|
1995-08-01 |
1999-09-28 |
ノバルティス・アクチエンゲゼルシャフト |
リポソームオリゴヌクレオチド組成物
|
US6093816A
(en)
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
US7262173B2
(en)
|
1997-03-21 |
2007-08-28 |
Georgetown University |
Chemosensitizing with liposomes containing oligonucleotides
|
JP4656675B2
(ja)
|
1997-05-14 |
2011-03-23 |
ユニバーシティー オブ ブリティッシュ コロンビア |
脂質小胞への荷電した治療剤の高率封入
|
AU8428998A
(en)
|
1997-07-24 |
1999-02-16 |
Inex Pharmaceuticals Corporation |
Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method
|
US6410328B1
(en)
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6656498B1
(en)
|
1998-11-25 |
2003-12-02 |
Vanderbilt University |
Cationic liposomes for gene transfer
|
AU5905400A
(en)
|
1999-07-14 |
2001-02-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions for delivery and retention of active agents to lymph nodes
|
US7094423B1
(en)
|
1999-07-15 |
2006-08-22 |
Inex Pharmaceuticals Corp. |
Methods for preparation of lipid-encapsulated therapeutic agents
|
ES2336766T3
(es)
|
2000-10-04 |
2010-04-16 |
Kyowa Hakko Kirin Co., Ltd. |
Procedimiento de recubrimiento de particulas finas con pelicula lipidica.
|
US7713942B2
(en)
|
2001-04-04 |
2010-05-11 |
Nordic Vaccine Technology A/S |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
|
US20030077829A1
(en)
|
2001-04-30 |
2003-04-24 |
Protiva Biotherapeutics Inc.. |
Lipid-based formulations
|
WO2002088370A2
(en)
|
2001-04-30 |
2002-11-07 |
Protiva Biotherapeutics Inc. |
Autogene nucleic acids encoding a secretable rna polymerase
|
WO2003039595A2
(en)
|
2001-11-07 |
2003-05-15 |
Inex Pharmaceuticals Corporation |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
JP4722481B2
(ja)
|
2002-06-28 |
2011-07-13 |
プロティバ バイオセラピューティクス リミテッド |
リポソーム製造方法および装置
|
CA2532228C
(en)
|
2003-07-16 |
2017-02-14 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
CN1882693B
(zh)
|
2003-09-15 |
2012-08-15 |
普洛体维生物治疗公司 |
聚乙二醇修饰的脂质化合物及其应用
|
JP2007526322A
(ja)
|
2004-03-02 |
2007-09-13 |
マサチューセッツ インスティテュート オブ テクノロジー |
ナノセル薬物送達系
|
EP1781593B1
(en)
|
2004-06-07 |
2011-12-14 |
Protiva Biotherapeutics Inc. |
Cationic lipids and methods of use
|
JP4796062B2
(ja)
|
2004-06-07 |
2011-10-19 |
プロチバ バイオセラピューティクス インコーポレイティッド |
脂質封入干渉rna
|
WO2006002538A1
(en)
|
2004-07-02 |
2006-01-12 |
Protiva Biotherapeutics, Inc. |
Immunostimulatory sirna molecules and uses therefor
|
WO2006007712A1
(en)
|
2004-07-19 |
2006-01-26 |
Protiva Biotherapeutics, Inc. |
Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
|
US20060134189A1
(en)
|
2004-11-17 |
2006-06-22 |
Protiva Biotherapeutics, Inc |
siRNA silencing of apolipoprotein B
|
WO2006113679A2
(en)
|
2005-04-15 |
2006-10-26 |
Board Of Regents, The University Of Texas System |
Delivery of sirna by neutral lipid compositions
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
US20080088046A1
(en)
|
2006-10-13 |
2008-04-17 |
Steffen Panzner |
Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome
|
US20070087045A1
(en)
|
2005-10-14 |
2007-04-19 |
Industrial Technology Research Institute |
Lipid carrier and method of preparing the same
|
US7838658B2
(en)
|
2005-10-20 |
2010-11-23 |
Ian Maclachlan |
siRNA silencing of filovirus gene expression
|
EP2395012B8
(en)
|
2005-11-02 |
2018-06-06 |
Arbutus Biopharma Corporation |
Modified siRNA molecules and uses thereof
|
US20070218122A1
(en)
|
2005-11-18 |
2007-09-20 |
Protiva Biotherapeutics, Inc. |
siRNA silencing of influenza virus gene expression
|
US8598333B2
(en)
|
2006-05-26 |
2013-12-03 |
Alnylam Pharmaceuticals, Inc. |
SiRNA silencing of genes expressed in cancer
|
US20080171716A1
(en)
|
2006-08-16 |
2008-07-17 |
Protiva Biotherapeutics, Inc. |
Nucleic acid modulation of toll-like receptor-mediated immune stimulation
|
KR101333279B1
(ko)
*
|
2006-10-06 |
2013-11-27 |
에스씨아이엘 테크놀로지 게엠베하 |
약학적 응용을 위한 건조된 재구성 소포 형성
|
WO2009051451A2
(en)
|
2007-10-17 |
2009-04-23 |
Korea Advanced Institute Of Science And Technology |
Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
|
JP5697988B2
(ja)
*
|
2007-12-27 |
2015-04-08 |
プロチバ バイオセラピューティクス インコーポレイティッド |
干渉rnaを使用したポロ様キナーゼ発現のサイレンシング方法
|
PT2279254T
(pt)
|
2008-04-15 |
2017-09-04 |
Protiva Biotherapeutics Inc |
Novas formulações lipídicas para entrega de ácido nucleico
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
EP2304026A4
(en)
|
2008-07-31 |
2013-12-18 |
Belrose Pharma Inc |
NANOPARTICLE COMPOSITIONS FOR A NUCLEIC ACID DELIVERY SYSTEM
|
CN104119242B
(zh)
|
2008-10-09 |
2017-07-07 |
泰米拉制药公司 |
改善的氨基脂质和递送核酸的方法
|
IL281434B2
(en)
|
2008-10-20 |
2023-09-01 |
Alnylam Pharmaceuticals Inc |
Compounds and methods for inhibiting transthyretin expression
|
WO2010054401A1
(en)
|
2008-11-10 |
2010-05-14 |
Alnylam Pharmaceuticals, Inc. |
Novel lipids and compositions for the delivery of therapeutics
|
WO2010056403A1
(en)
|
2008-11-17 |
2010-05-20 |
Enzon Pharmaceuticals, Inc. |
Branched cationic lipids for nucleic acids delivery system
|
JP2012509272A
(ja)
|
2008-11-17 |
2012-04-19 |
エンゾン ファーマシューティカルズ,インコーポレーテッド |
核酸送達系のための放出性カチオン脂質
|
US10292932B2
(en)
|
2008-12-26 |
2019-05-21 |
Samyang Biopharmaceuticals Corporation |
Polymeric micelle particle comprising anionic drugs and method of preparing the same
|
US20120015026A1
(en)
|
2009-03-25 |
2012-01-19 |
Giancarlo Francese |
Pharmaceutical composition containing a drug and sirna
|
NZ596186A
(en)
|
2009-05-05 |
2014-03-28 |
Alnylam Pharmaceuticals Inc |
Lipid compositions
|
TR201811076T4
(tr)
|
2009-06-10 |
2018-08-27 |
Arbutus Biopharma Corp |
Geliştirilmiş lipit formulasyonu.
|
WO2011000107A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
AP3574A
(en)
*
|
2009-08-14 |
2016-02-08 |
Alnylam Pharmaceuticals Inc |
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
|
EP2475675B1
(en)
|
2009-09-11 |
2016-11-16 |
Ionis Pharmaceuticals, Inc. |
Modulation of huntingtin expression
|
JP5823405B2
(ja)
|
2009-11-04 |
2015-11-25 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
核酸含有脂質粒子および関連方法
|
EP3318248B1
(en)
|
2009-12-01 |
2019-04-10 |
Translate Bio, Inc. |
Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
|
US8795726B2
(en)
|
2010-01-19 |
2014-08-05 |
Polypid Ltd. |
Sustained-release nucleic acid matrix compositions
|
US10077232B2
(en)
|
2010-05-12 |
2018-09-18 |
Arbutus Biopharma Corporation |
Cyclic cationic lipids and methods of use
|
KR101198715B1
(ko)
|
2010-05-14 |
2012-11-13 |
한국생명공학연구원 |
핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
|
US20100239521A1
(en)
|
2010-06-01 |
2010-09-23 |
Mohammad Reza Mozafari |
Method for the preparation of micro- and nano-sized carrier systems for the encapsulation of bioactive substances
|
DK2575764T3
(en)
|
2010-06-03 |
2017-08-07 |
Alnylam Pharmaceuticals Inc |
BIODEGRADABLE LIPIDS FOR THE ACTIVATION OF ACTIVE AGENTS
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
ES2935542T3
(es)
|
2010-08-31 |
2023-03-07 |
Glaxosmithkline Biologicals Sa |
Liposomas pequeños para la administración de ARN que codifica para inmunógeno
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
CA2838063C
(en)
|
2011-06-08 |
2023-07-11 |
Shire Human Genetic Therapies, Inc. |
Cleavable lipids
|
NZ719345A
(en)
*
|
2011-06-08 |
2023-03-31 |
Translate Bio Inc |
Lipid nanoparticle compositions and methods for mrna delivery
|
US9011903B2
(en)
|
2011-06-08 |
2015-04-21 |
Nitto Denko Corporation |
Cationic lipids for therapeutic agent delivery formulations
|
WO2013004234A2
(en)
|
2011-07-04 |
2013-01-10 |
Statens Serum Institut |
Methods for producing liposomes
|
US9126966B2
(en)
|
2011-08-31 |
2015-09-08 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
JP2014525461A
(ja)
|
2011-08-31 |
2014-09-29 |
ノバルティス アーゲー |
免疫原をコードするrnaの送達のためのpeg化リポソーム
|
JP2014530602A
(ja)
|
2011-10-05 |
2014-11-20 |
プロティバ バイオセラピューティクス インコーポレイテッド |
アルデヒドデヒドロゲナーゼをサイレンシングするための組成物および方法
|
TR201904389T4
(tr)
|
2011-11-04 |
2019-04-22 |
Nitto Denko Corp |
Lipit nükleik asit partiküllerinin steril bir şekilde üretilmesine yönelik yöntem.
|
US9579338B2
(en)
|
2011-11-04 |
2017-02-28 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
CA2859387A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
DK2817287T3
(da)
|
2012-02-24 |
2019-01-02 |
Arbutus Biopharma Corp |
Trialkyl kationisk lipid og metoder til anvendelse deraf
|
WO2013130824A1
(en)
|
2012-02-29 |
2013-09-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
JP6283655B2
(ja)
|
2012-03-29 |
2018-02-21 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
イオン化可能なカチオン性脂質
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
US20160289674A1
(en)
|
2012-04-02 |
2016-10-06 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of membrane proteins
|
WO2013151669A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
ES2864878T3
(es)
|
2012-06-08 |
2021-10-14 |
Translate Bio Inc |
Administración pulmonar de ARN, a células objetivo no pulmonares
|
EP3489220B9
(en)
|
2012-06-08 |
2021-11-10 |
Nitto Denko Corporation |
Lipids for therapeutic agent delivery formulations
|
EP3750903A1
(en)
|
2013-03-14 |
2020-12-16 |
Translate Bio, Inc. |
Ribonucleic acids with 4'-thio-modified nucleotides and related methods
|
JP6399560B2
(ja)
|
2013-03-14 |
2018-10-03 |
トランスレイト バイオ, インコーポレイテッド |
mRNAによってコードされる抗体を送達するための方法及び組成物
|
CA2906732C
(en)
|
2013-03-15 |
2023-08-08 |
The University Of British Columbia |
Lipid nanoparticles for transfection and related methods
|
ES2670529T3
(es)
|
2013-03-15 |
2018-05-30 |
Translate Bio, Inc. |
Mejora sinergística de la entrega de ácidos nucleicos a través de formulaciones mezcladas
|
KR102109188B1
(ko)
|
2013-04-01 |
2020-05-11 |
삼성전자주식회사 |
양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도
|
JP2016528890A
(ja)
*
|
2013-07-09 |
2016-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
CRISPR/Cas系を用いるゲノム編集の治療用の使用
|
US20160151284A1
(en)
|
2013-07-23 |
2016-06-02 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
WO2015021465A2
(en)
|
2013-08-09 |
2015-02-12 |
New York University |
Protein engineered systems for delivery of molecules
|
EP4036241A1
(en)
|
2013-10-22 |
2022-08-03 |
Translate Bio, Inc. |
Cns delivery of mrna and uses thereof
|
CN112656954A
(zh)
|
2013-10-22 |
2021-04-16 |
夏尔人类遗传性治疗公司 |
用于递送信使rna的脂质制剂
|
WO2015061500A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for argininosuccinate synthetase deficiency
|
CN105658242A
(zh)
|
2013-10-22 |
2016-06-08 |
夏尔人类遗传性治疗公司 |
用于苯丙酮尿症的mrna疗法
|
US10561610B2
(en)
|
2014-01-21 |
2020-02-18 |
Anjarium Biosciences Ag |
Hybridosomes, compositions comprising the same, processes for their production and uses thereof
|
DK3116997T3
(da)
|
2014-03-10 |
2019-08-19 |
Editas Medicine Inc |
Crispr/cas-relaterede fremgangsmåder og sammensætninger til behandling af lebers kongenitale amaurose 10 (lca10)
|
EP3122878B1
(en)
|
2014-03-24 |
2018-10-24 |
Translate Bio, Inc. |
Mrna therapy for the treatment of ocular diseases
|
WO2015154002A1
(en)
|
2014-04-04 |
2015-10-08 |
Ohio State Innovation Foundation |
Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same
|
BR112016024644A2
(pt)
*
|
2014-04-23 |
2017-10-10 |
Modernatx Inc |
vacinas de ácido nucleico
|
WO2015184256A2
(en)
|
2014-05-30 |
2015-12-03 |
Shire Human Genetic Therapies, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
EP3155116A4
(en)
|
2014-06-10 |
2017-12-27 |
Massachusetts Institute Of Technology |
Method for gene editing
|
EP3160959B1
(en)
|
2014-06-24 |
2023-08-30 |
Translate Bio, Inc. |
Stereochemically enriched compositions for delivery of nucleic acids
|
EP3160448A4
(en)
|
2014-06-26 |
2018-11-14 |
Ramot at Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
EP3164112A1
(en)
|
2014-07-02 |
2017-05-10 |
Shire Human Genetic Therapies, Inc. |
Encapsulation of messenger rna
|
US9943595B2
(en)
|
2014-12-05 |
2018-04-17 |
Translate Bio, Inc. |
Messenger RNA therapy for treatment of articular disease
|
CN114642735A
(zh)
*
|
2015-01-21 |
2022-06-21 |
菲泽尔克斯公司 |
用于将治疗剂和诊断剂递送到细胞中的方法、组合物和***
|
EP3247398A4
(en)
|
2015-01-23 |
2018-09-26 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
EP3900702A1
(en)
*
|
2015-03-19 |
2021-10-27 |
Translate Bio, Inc. |
Mrna therapy for pompe disease
|
US10920246B2
(en)
|
2015-05-26 |
2021-02-16 |
Ramot At Tel-Aviv University Ltd. |
Targeted lipid particles for systemic delivery of nucleic acid molecules to leukocytes
|
CA2989884A1
(en)
|
2015-07-09 |
2017-01-12 |
Insmed Incorporated |
Compositions and methods for treating lung diseases and lung injury
|
SI3350157T1
(sl)
|
2015-09-17 |
2022-04-29 |
Modernatx, Inc. |
Sestave za doziranje terapevtskih sredstev v celice
|
EP3364950A4
(en)
|
2015-10-22 |
2019-10-23 |
ModernaTX, Inc. |
VACCINES AGAINST TROPICAL DISEASES
|
CA3003090A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Cancer vaccines
|
JP6921833B2
(ja)
|
2015-10-22 |
2021-08-18 |
モデルナティーエックス, インコーポレイテッド |
ヒトサイトメガロウイルスワクチン
|
WO2017075038A1
(en)
|
2015-10-26 |
2017-05-04 |
Rana Therapeutics, Inc. |
Nanoparticle formulations for delivery of nucleic acid complexes
|
AU2016366978B2
(en)
|
2015-12-10 |
2022-07-28 |
Modernatx, Inc. |
Compositions and methods for delivery of therapeutic agents
|
NZ743320A
(en)
|
2015-12-18 |
2019-03-29 |
Samyang Biopharmaceuticals |
Method for preparing polymeric micelle containing anionic drug
|
HUE057877T2
(hu)
|
2015-12-22 |
2022-06-28 |
Modernatx Inc |
Vegyületek és készítmények terápiás szerek intracelluláris bejuttatására
|
CN107281103A
(zh)
|
2016-04-11 |
2017-10-24 |
百奥迈科生物技术有限公司 |
具有高含量阳性脂质化合物的脂质体制剂及其应用
|
WO2017201332A1
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding acyl-coa dehydrogenase, very long-chain for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
WO2017201258A1
(en)
|
2016-05-18 |
2017-11-23 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
WO2017218524A1
(en)
|
2016-06-13 |
2017-12-21 |
Rana Therapeutics, Inc. |
Messenger rna therapy for the treatment of ornithine transcarbamylase deficiency
|
CA3027201A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
US20210284998A1
(en)
|
2016-10-03 |
2021-09-16 |
Precision Nanosystems Inc. |
Compositions for Transfecting Resistant Cell Types
|
MA46584A
(fr)
|
2016-10-21 |
2019-08-28 |
Modernatx Inc |
Vaccin contre le cytomégalovirus humain
|
IL266194B2
(en)
|
2016-10-26 |
2023-09-01 |
Curevac Ag |
mRNA vaccines with lipid nanoparticles
|
EP3538067A1
(en)
|
2016-11-08 |
2019-09-18 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
CN110167922B
(zh)
|
2016-11-08 |
2023-09-19 |
特拉维夫大学拉莫特有限公司 |
用于核酸递送的阳离子脂质及其制备
|
MA46762A
(fr)
|
2016-11-10 |
2019-09-18 |
Translate Bio Inc |
Procédé amélioré de préparation de nanoparticules lipidiques chargées d'arnm
|
WO2018089790A1
(en)
|
2016-11-10 |
2018-05-17 |
Translate Bio, Inc. |
Improved ice-based lipid nanoparticle formulation for delivery of mrna
|
US20180185516A1
(en)
|
2016-12-09 |
2018-07-05 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
US10383952B2
(en)
|
2016-12-21 |
2019-08-20 |
Arcturus Therapeutics, Inc. |
Ionizable cationic lipid for RNA delivery
|
RS63953B1
(sr)
|
2017-03-15 |
2023-02-28 |
Modernatx Inc |
Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
|
CA3055653A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
EP3625342B1
(en)
*
|
2017-05-18 |
2022-08-24 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
MX2019014435A
(es)
|
2017-05-30 |
2020-01-27 |
Glaxosmithkline Biologicals Sa |
Procedimientos para la fabricacion de un arn encapsulado en liposoma.
|
WO2018231990A2
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase
|
US20210198200A1
(en)
|
2017-06-14 |
2021-07-01 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
EP3638215A4
(en)
|
2017-06-15 |
2021-03-24 |
Modernatx, Inc. |
RNA FORMULATIONS
|
EP3641834B1
(en)
|
2017-06-19 |
2023-10-04 |
Translate Bio, Inc. |
Messenger rna therapy for the treatment of friedreich's ataxia
|
BR112020000839A2
(pt)
|
2017-07-14 |
2020-07-21 |
Oncorus, Inc. |
polinucleotídeos encapsulados e métodos de uso
|
JP7429536B2
(ja)
|
2017-08-04 |
2024-02-08 |
協和キリン株式会社 |
核酸含有脂質ナノ粒子
|
EP3668833A1
(en)
|
2017-08-16 |
2020-06-24 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
EP3668834A1
(en)
|
2017-08-17 |
2020-06-24 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
US11542225B2
(en)
|
2017-08-17 |
2023-01-03 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
MX2020002348A
(es)
|
2017-08-31 |
2020-10-08 |
Modernatx Inc |
Métodos de elaboración de nanopartículas lipídicas.
|
WO2019089828A1
(en)
|
2017-10-31 |
2019-05-09 |
Acuitas Therapeutics, Inc. |
Lamellar lipid nanoparticles
|
CN111565706A
(zh)
|
2017-11-09 |
2020-08-21 |
免疫疫苗技术公司 |
药物组合物、包括脂质囊泡颗粒尺寸设定的制备方法及其用途
|
AU2018379379A1
(en)
|
2017-12-06 |
2020-06-18 |
Newsouth Innovations Pty Limited |
Liposomal system for drug delivery
|
US11951210B2
(en)
|
2017-12-12 |
2024-04-09 |
The Johns Hopkins Universty |
Methods for making giant vesicles and their use
|
WO2019126593A1
(en)
|
2017-12-20 |
2019-06-27 |
Translate Bio, Inc. |
Improved composition and methods for treatment of ornithine transcarbamylase deficiency
|
US20210024928A1
(en)
|
2018-02-16 |
2021-01-28 |
Mina Therapeutics Limited |
C/ebp alpha sarna compositions and methods of use
|
WO2019169203A1
(en)
|
2018-02-28 |
2019-09-06 |
Exicure, Inc. |
Liposomal spherical nucleic acid (sna) constructs for survival of motor neuron (sma) inhibitors
|
CA3095125A1
(en)
|
2018-03-27 |
2019-10-03 |
Factor Bioscience Inc. |
Nucleic acid-based therapeutics
|
US20230149310A1
(en)
|
2018-03-30 |
2023-05-18 |
Arcturus Therapeutics, Inc. |
Lipid particles for nucleic acid delivery
|
EP4227319A1
(en)
|
2018-04-17 |
2023-08-16 |
CureVac SE |
Novel rsv rna molecules and compositions for vaccination
|
EP3787688A4
(en)
|
2018-04-29 |
2021-11-17 |
Precision Nanosystems Inc |
COMPOSITIONS FOR TRANSFECTION OF RESISTANT CELL TYPES
|
KR20210014638A
(ko)
|
2018-05-01 |
2021-02-09 |
프레드 헛친슨 켄서 리서치 센터 |
유전자 발현을 위한 나노입자 및 이의 용도
|
US20210189397A1
(en)
|
2018-05-10 |
2021-06-24 |
Northwestern University |
Self-manageable abnormal scar treatment with spherical nucleic acid (sna) technology
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
CN117430538A
(zh)
|
2018-05-24 |
2024-01-23 |
川斯勒佰尔公司 |
硫酯阳离子脂质
|
EP3823634A4
(en)
|
2018-07-21 |
2022-08-03 |
University of Tennessee Research Foundation |
NEUTRAL LIPOSOMES CONTAINING BIOLOGICAL ACTIVE INGREDIENTS
|
EP3826608A1
(en)
|
2018-07-23 |
2021-06-02 |
Translate Bio, Inc. |
Dry power formulations for messenger rna
|
US20210315820A1
(en)
|
2018-07-30 |
2021-10-14 |
Trucode Gene Repair, Inc. |
Lipid nanoparticle formulations comprising nucleic acid mimics
|
EP3846857A4
(en)
*
|
2018-09-04 |
2022-10-12 |
The Board Of Regents Of The University Of Texas System |
COMPOSITIONS AND METHODS FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACIDS
|
WO2020051243A1
(en)
|
2018-09-04 |
2020-03-12 |
Ohio State Innovation Foundation |
Lipid nanoparticles and methods of using thereof
|
WO2020056294A1
(en)
|
2018-09-14 |
2020-03-19 |
Translate Bio, Inc. |
Composition and methods for treatment of methylmalonic acidemia
|
JP7410135B2
(ja)
|
2018-09-19 |
2024-01-09 |
モデルナティエックス インコーポレイテッド |
治療薬の細胞内送達のための化合物及び組成物
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
PT3864163T
(pt)
|
2018-10-09 |
2024-04-30 |
Univ British Columbia |
Composições e sistemas que compreendem vesículas competentes para transfeção isentas de solventes orgânicos e detergentes e métodos relacionados com as mesmas
|
US20220016265A1
(en)
|
2018-11-09 |
2022-01-20 |
Translate Bio, Inc. |
Messenger rna therapy for treatment of ocular diseases
|
KR20210105888A
(ko)
|
2018-11-09 |
2021-08-27 |
아뷰터스 바이오파마 코포레이션 |
규소를 포함하는 양이온성 지질
|
WO2020097379A2
(en)
|
2018-11-09 |
2020-05-14 |
Translate Bio, Inc. |
Peg lipidoid compounds
|
US20220001029A1
(en)
|
2018-11-09 |
2022-01-06 |
Arbutus Biopharma Corporation |
Lipid nanoparticle formulations
|
US20220072154A1
(en)
|
2018-11-09 |
2022-03-10 |
Arbutus Biopharma Corporation |
Negatively charged peg-lipid conjugates
|
EP3880174A2
(en)
|
2018-11-12 |
2021-09-22 |
Translate Bio, Inc. |
Methods for inducing immune tolerance
|
WO2020102668A1
(en)
|
2018-11-16 |
2020-05-22 |
Nitto Denko Corporation |
Rna interference delivery formulation and methods for malignant tumors
|
MX2021005969A
(es)
|
2018-11-21 |
2021-09-14 |
Translate Bio Inc |
Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr nebulizado.
|
US20220117902A1
(en)
|
2019-01-04 |
2022-04-21 |
Oncorus, Inc. |
Encapsulated rna polynucleotides and methods of use
|
US20220023214A1
(en)
|
2019-01-24 |
2022-01-27 |
CannaClear Inc. |
Lecithin Vesicles for Oral Delivery
|
EP3914236A4
(en)
|
2019-01-24 |
2022-10-26 |
Northwestern University |
HIGH-DENSITY LIPOPROTEINMIMETIC NANOPARTICLES USING LIPID-CONJUGATED CORE SCAFFOLDINGS
|
BR112021014845A2
(pt)
|
2019-01-31 |
2021-11-03 |
Modernatx Inc |
Métodos de preparação de nanopartículas lipídicas
|
EP3918082A4
(en)
|
2019-01-31 |
2022-11-16 |
NewSouth Innovations Pty Limited |
LIPOSOMAL NANOPARTICLES
|
BR112021018526A2
(pt)
|
2019-03-19 |
2021-11-23 |
Arcturus Therapeutics Inc |
Método de fabricação de nanopartículas de rna encapsuladas em lipídio
|
JPWO2020189773A1
(sr)
|
2019-03-20 |
2020-09-24 |
|
|
WO2020210901A1
(en)
|
2019-04-15 |
2020-10-22 |
Precision Nanosystems Inc. |
Nonviral modification of t cell gene expression
|
KR20220004675A
(ko)
|
2019-05-03 |
2022-01-11 |
다이서나 파마수이티컬, 인크. |
단축 센스 가닥을 갖는 이중 가닥 핵산 억제제 분자
|
MA55896A
(fr)
|
2019-05-07 |
2022-03-16 |
Modernatx Inc |
Polynucléotides servant à perturber l'activité de cellule immunitaire et procédés pour les utiliser
|
CA3140423A1
(en)
|
2019-05-14 |
2020-11-19 |
Translate Bio, Inc. |
Improved process of preparing mrna-loaded lipid nanoparticles
|
JP2022538797A
(ja)
|
2019-06-14 |
2022-09-06 |
ディーエヌエーライト セラピューティクス, インコーポレイテッド |
生物学的送達ビヒクルのための組成物及び方法
|
EP3986452A1
(en)
|
2019-06-18 |
2022-04-27 |
CureVac AG |
Rotavirus mrna vaccine
|
JP7416096B2
(ja)
|
2019-06-20 |
2024-01-17 |
プレシジョン ナノシステムズ ユーエルシー |
核酸送達のためのイオン化可能な脂質
|
US20220378917A1
(en)
|
2019-06-29 |
2022-12-01 |
Precision NanoSystems ULC |
Ionizable lipids for nucleic acid delivery
|
JP2022542562A
(ja)
|
2019-07-23 |
2022-10-05 |
トランスレイト バイオ, インコーポレイテッド |
mRNA担持脂質ナノ粒子の安定性組成物および作製のプロセス
|
JP2022542389A
(ja)
|
2019-07-29 |
2022-10-03 |
ジョージア テック リサーチ コーポレイション |
拘束された脂質を含むナノ材料およびその使用
|
CN114729030A
(zh)
|
2019-07-30 |
2022-07-08 |
沃达瑞公司 |
病毒样颗粒疫苗
|
WO2021022173A1
(en)
|
2019-07-31 |
2021-02-04 |
Modernatx, Inc. |
Compositions and methods for delivery of rna interference agents to immune cells
|
US20220296517A1
(en)
|
2019-08-07 |
2022-09-22 |
Moderna TX, Inc. |
Compositions and methods for enhanced delivery of agents
|
AU2020328855A1
(en)
|
2019-08-14 |
2022-03-03 |
CureVac SE |
RNA combinations and compositions with decreased immunostimulatory properties
|
ES2918001A2
(es)
|
2019-08-14 |
2022-07-13 |
Acuitas Therapeutics Inc |
Nanoparticulas lipidicas mejoradas para el suministro de acidos nucleicos
|
US20230172858A1
(en)
|
2019-08-30 |
2023-06-08 |
Glaxosmithkline Biologicals Sa |
Jet mixing lipid nanoparticle manufacturing process
|
EP4031191A4
(en)
|
2019-09-18 |
2023-10-25 |
The Regents of the University of California |
PROTEIN-PRODUCING NANOLIPOSOMES AND THEIR USES
|
TW202124360A
(zh)
|
2019-09-19 |
2021-07-01 |
美商現代公司 |
用於治療劑之細胞內遞送之支鏈尾端脂質化合物及組合物
|
US20230001021A1
(en)
|
2019-10-22 |
2023-01-05 |
Genevant Sciences Gmbh |
Ornithine transcarbamylase (otc) constructs and methods of using the same
|
JP2023502576A
(ja)
|
2019-11-22 |
2023-01-25 |
ジェネレーション バイオ カンパニー |
イオン化可能な脂質およびそれらのナノ粒子組成物
|
WO2021108731A1
(en)
|
2019-11-25 |
2021-06-03 |
The Methodist Hospital |
Aposome compositions and methods of use
|
EP3838266A1
(en)
|
2019-12-20 |
2021-06-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microfluidic production of biofunctionalized giant unilamellar vesicles for targeted intracellular cargo delivery
|
AU2020417305A1
(en)
|
2019-12-31 |
2022-07-21 |
Fred Hutchinson Cancer Center |
Nanoparticle systems to stimulate and maintain immune system responsiveness at treatment sites
|
EP3858332A1
(en)
|
2020-01-31 |
2021-08-04 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bottom-up assembly of synthetic extracellular vesicles
|
US20230285297A1
(en)
|
2020-01-31 |
2023-09-14 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
EP4147717A1
(en)
|
2020-02-04 |
2023-03-15 |
CureVac SE |
Coronavirus vaccine
|
CN113186203B
(zh)
|
2020-02-13 |
2022-12-30 |
斯微(上海)生物科技股份有限公司 |
治疗或者预防冠状病毒病的疫苗试剂
|
EP4110296A1
(en)
|
2020-02-25 |
2023-01-04 |
Translate Bio, Inc. |
Improved processes of preparing mrna-loaded lipid nanoparticles
|
CN113999184A
(zh)
|
2020-02-28 |
2022-02-01 |
深圳深信生物科技有限公司 |
一种胺基脂质化合物、其制备方法和应用
|
EP4125821A4
(en)
|
2020-03-27 |
2024-06-26 |
Generation Bio Co. |
NOVEL LIPIDS AND ASSOCIATED NANOPARTICLE COMPOSITIONS
|
US11559577B2
(en)
|
2020-03-31 |
2023-01-24 |
Engimata, Inc. |
Immunogenic composition forming a vaccine, and a method for its manufacture
|
CN113456591B
(zh)
|
2020-03-31 |
2022-06-14 |
武汉合生科技有限公司 |
糖基聚醚类化合物脂质体及其制备方法和药物
|
EP4132584A4
(en)
|
2020-04-07 |
2024-05-01 |
The Regents Of The University Of California |
MANUFACTURE OF SYNTHETIC EXOSOMES FOR CNS AND NON-CNS DELIVERY OF THERAPEUTIC AGENTS
|
WO2021207630A1
(en)
|
2020-04-10 |
2021-10-14 |
Northwestern University |
Oxidized tumor cell lysates encapsulated in liposomal spherical nucleic acids as potent cancer immunotherapeutics
|
GB202307565D0
(en)
|
2020-04-22 |
2023-07-05 |
BioNTech SE |
Coronavirus vaccine
|
AU2021263590A1
(en)
|
2020-05-01 |
2023-01-19 |
Arcturus Therapeutics, Inc. |
Nucleic acids and methods of treatment for cystic fibrosis
|
WO2021226463A1
(en)
|
2020-05-07 |
2021-11-11 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
EP4146342A1
(en)
|
2020-05-07 |
2023-03-15 |
Translate Bio, Inc. |
Improved compositions for cftr mrna therapy
|
AU2021273502A1
(en)
|
2020-05-15 |
2023-02-02 |
Translate Bio, Inc. |
Lipid nanoparticle formulations for mRNA delivery
|
AU2021274481A1
(en)
|
2020-05-18 |
2022-11-03 |
Generation Bio Co. |
Novel lipids and nanoparticle compositions thereof
|
BR112022023352A2
(pt)
|
2020-05-18 |
2023-05-02 |
Max Biology Co Ltd |
Composições, método para fornecer um agente bioativo, preparar uma pluralidade de partículas compósitas, tratar doença do olho seco e tratar uma doença ou afecção e método de uso recreativo
|
BR112022023554A2
(pt)
|
2020-05-19 |
2023-04-11 |
Orna Therapeutics Inc |
Composições e métodos de rna circular
|
WO2021236763A2
(en)
|
2020-05-20 |
2021-11-25 |
Nitto Denko Corporation |
dsRNA DIRECTED TO CORONAVIRUS PROTEINS
|
BR112022024248A2
(pt)
|
2020-05-29 |
2023-10-10 |
CureVac SE |
Vacinas de combinação à base de ácido nucleico
|
US20230416308A1
(en)
|
2020-05-29 |
2023-12-28 |
Oncorus, Inc. |
Encapsulated rna replicons and methods of use
|
WO2022009052A2
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
WO2022015809A2
(en)
|
2020-07-14 |
2022-01-20 |
The Research Foundation for the State Universtiy of New York |
Asymmetric charged vesicles and methods of preparing and use thereof
|
IL299896A
(en)
|
2020-07-17 |
2023-03-01 |
Generation Bio Co |
Methods for thermoforming polynucleotides into reduced sizes of lipid nanoparticles and their new formulation
|
GB202011367D0
(en)
|
2020-07-22 |
2020-09-02 |
Micropore Tech Limited |
Method of preparing liposomes
|
US20230293434A1
(en)
|
2020-07-23 |
2023-09-21 |
The Regents Of The University Of California |
COMPOSITIONS COMPRISING miR-690 AND METHODS THEREFOR
|
AU2021322310A1
(en)
|
2020-08-06 |
2023-04-13 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
CA3189854A1
(en)
|
2020-08-06 |
2022-02-10 |
Modernatx, Inc. |
Compositions for the delivery of payload molecules to airway epithelium
|
WO2022040429A2
(en)
|
2020-08-19 |
2022-02-24 |
Vitruviae LLC |
Vaccine compositions and antibodies for lyme disease
|
WO2022046919A2
(en)
|
2020-08-25 |
2022-03-03 |
The Regents Of The University Of California |
Compositions and methods for the treatment of ocular neuroinflammation
|
EP4157344A2
(en)
|
2020-08-31 |
2023-04-05 |
CureVac SE |
Multivalent nucleic acid based coronavirus vaccines
|
CA3189903A1
(en)
|
2020-09-11 |
2022-03-17 |
Wilfred Jefferies |
Vaccine for viral pathogens
|